These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cell death pathways in Parkinson's disease: role of mitochondria. Yao Z; Wood NW Antioxid Redox Signal; 2009 Sep; 11(9):2135-49. PubMed ID: 19422283 [TBL] [Abstract][Full Text] [Related]
4. α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease. Cooper JF; Spielbauer KK; Senchuk MM; Nadarajan S; Colaiácovo MP; Van Raamsdonk JM Exp Neurol; 2018 Dec; 310():58-69. PubMed ID: 30194957 [TBL] [Abstract][Full Text] [Related]
5. What genetics tells us about the causes and mechanisms of Parkinson's disease. Corti O; Lesage S; Brice A Physiol Rev; 2011 Oct; 91(4):1161-218. PubMed ID: 22013209 [TBL] [Abstract][Full Text] [Related]
9. Parkinson's disease: from genetics to treatments. Fan HC; Chen SJ; Harn HJ; Lin SZ Cell Transplant; 2013; 22(4):639-52. PubMed ID: 23127617 [TBL] [Abstract][Full Text] [Related]
10. New Developments in Genetic rat models of Parkinson's Disease. Creed RB; Goldberg MS Mov Disord; 2018 May; 33(5):717-729. PubMed ID: 29418019 [TBL] [Abstract][Full Text] [Related]
11. Animal models for Parkinson's disease. Patil DA; Patil VA; Bari SB; Surana SJ; Patil PO CNS Neurol Disord Drug Targets; 2014; 13(9):1580-94. PubMed ID: 25106631 [TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease: genetic versus toxin-induced rodent models. Terzioglu M; Galter D FEBS J; 2008 Apr; 275(7):1384-1391. PubMed ID: 18279376 [TBL] [Abstract][Full Text] [Related]
13. Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration. Gispert S; Ricciardi F; Kurz A; Azizov M; Hoepken HH; Becker D; Voos W; Leuner K; Müller WE; Kudin AP; Kunz WS; Zimmermann A; Roeper J; Wenzel D; Jendrach M; García-Arencíbia M; Fernández-Ruiz J; Huber L; Rohrer H; Barrera M; Reichert AS; Rüb U; Chen A; Nussbaum RL; Auburger G PLoS One; 2009 Jun; 4(6):e5777. PubMed ID: 19492057 [TBL] [Abstract][Full Text] [Related]
14. DJ-1: a newcomer in Parkinson's disease pathology. da Costa CA Curr Mol Med; 2007 Nov; 7(7):650-7. PubMed ID: 18045143 [TBL] [Abstract][Full Text] [Related]
15. Back and to the Future: From Neurotoxin-Induced to Human Parkinson's Disease Models. Airavaara M; Parkkinen I; Konovalova J; Albert K; Chmielarz P; Domanskyi A Curr Protoc Neurosci; 2020 Mar; 91(1):e88. PubMed ID: 32049438 [TBL] [Abstract][Full Text] [Related]
16. Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein. Lu XH; Fleming SM; Meurers B; Ackerson LC; Mortazavi F; Lo V; Hernandez D; Sulzer D; Jackson GR; Maidment NT; Chesselet MF; Yang XW J Neurosci; 2009 Feb; 29(7):1962-76. PubMed ID: 19228951 [TBL] [Abstract][Full Text] [Related]
17. Human Induced Pluripotent Stem Cell Phenotyping and Preclinical Modeling of Familial Parkinson's Disease. Kim J; Daadi EW; Oh T; Daadi ES; Daadi MM Genes (Basel); 2022 Oct; 13(11):. PubMed ID: 36360174 [TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of Parkinson's disease-associated genes in mice reveals altered survival and bioenergetics of Parkin-deficient dopamine neurons. Giguère N; Pacelli C; Saumure C; Bourque MJ; Matheoud D; Levesque D; Slack RS; Park DS; Trudeau LÉ J Biol Chem; 2018 Jun; 293(25):9580-9593. PubMed ID: 29700116 [TBL] [Abstract][Full Text] [Related]
20. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease. Yasuda T; Mochizuki H Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]